COVID-19 resources / Clinical Research Insights and News

The Cohortias Blog

Stay informed

COVID-19 resources

Cohortias is bringing clinical research to Latin America, now proud to participate in COVID-19 clinical trials.

Our archive includes insights from our experts as they discuss lessons learned over the past three months in managing COVID-19’s impact on trials in Latin America and around the world.

Our blog posts provide insights into what companies should be doing now to prepare for the upcoming ‘new normal’.

liver cancer

First-in-Human – Treatment for Advanced Liver Cancer.

OUTREACH-2 study evaluating MTL-CEBPA in combination with sorafenib in up to 150 patients.

Chronic obstructive pulmonary disease

Clinical Trial – Chronic obstructive pulmonary disease.

Ensifentrine is a first-in-class product candidate that combines bronchodilator and anti-inflammatory activities in one compound.

atopic dermatitis

Clinical Trial – Phase IIb of atopic dermatitis antibody.

The trial is expected to enrol subjects across 100 sites in North America, Asia Pacific and Europe.


First-in-Patient – New Treatment of Parkinson’s Disease.

In preclinical studies, NE3107 was shown to improve motor symptoms as effectively as L-dopa.

COVID-19 Research - Free Consultation

The clinical development journey is fraught with pitfalls and roadblocks; COVID-19 has almost overnight added to the complexity. Innovations, technologies and reinvented processes can help. Our experienced team of experts shares experiences, lessons learned and tips to help you mitigate risk in the current environment while implementing some of the industry’s latest innovations.

covid clinical trials

The presence of clinical research in Latin America has been growing steadily for the last decade, mainly because of cost effectiveness, excellent patient recruitment and the emergence of FDA approved regulatory agencies.